Randomized controlled trials on the use of cannabis-based medicines in movement disorders: a systematic review P. OikonomouW. H. Jost Neurology and Preclinical Neurological Studies - Review Article 20 July 2022 Pages: 1247 - 1256
Neuromelanin granules of the substantia nigra: proteomic profile provides links to tyrosine hydroxylase, stress granules and lysosomes Maximilian WulfKatalin BarkovitsKatrin Marcus Neurology and Preclinical Neurological Studies - Original Article Open access 19 July 2022 Pages: 1257 - 1270
Do demographic and clinical features and comorbidities affect the risk of spread to an additional body site in functional motor disorders? Tommaso ErcoliMichele TinazziGiovanni Defazio Neurology and Preclinical Neurological Studies - Original Article Open access 16 August 2022 Pages: 1271 - 1276
Long-term effects of safinamide adjunct therapy on levodopa-induced dyskinesia in Parkinson’s disease: post-hoc analysis of a Japanese phase III study Nobutaka HattoriTakanori KameiYoshio Tsuboi Neurology and Preclinical Neurological Studies - Original Article Open access 24 August 2022 Pages: 1277 - 1287
Levodopa responsiveness in Parkinson’s disease: harnessing real-life experience with machine-learning analysis Ruth DjaldettiBen HadadBoaz Lerner Neurology and Preclinical Neurological Studies - Original Article 27 August 2022 Pages: 1289 - 1297
Wearable sensor device-based detection of decreased heart rate variability in Parkinson’s disease Masashi SuzukiTomohiko NakamuraMasahisa Katsuno Neurology and Preclinical Neurological Studies - Original Article 14 July 2022 Pages: 1299 - 1306
Corrections required for Dressler and Johnson 2022 Alberto EsquenaziMark ElliottAndreas Lysandropoulos Neurology and Preclinical Neurological Studies - Letter to the Editor Open access 30 August 2022 Pages: 1307 - 1308
Potency of botulinum toxin drugs: test systems and labelling Dirk DresslerEric A Johnson Neurology and Preclinical Neurological Studies - Short communication Open access 30 August 2022 Pages: 1309 - 1310
Correction to: Predict cognitive decline with clinical markers in Parkinson’s disease (PRECODE-1) Heather WilsonGennaro PaganoMarios Politis Correction Open access 01 March 2022 Pages: 1311 - 1311
Correction to: 5-HTT genotype and inertia of negative affect in adolescents and young adults from the general population T. M. OllmannE. SeidlK. Beesdo-Baum Correction Open access 22 March 2022 Pages: 1313 - 1314
Correction to: Non-credible symptom report in the clinical evaluation of adult ADHD: development and initial validation of a new validity index embedded in the Conners’ adult ADHD rating scales Miriam BeckeLara TuchaAnselm B. M. Fuermaier Correction Open access 17 August 2022 Pages: 1315 - 1319